 |
 |
raj, just copy the WHOLE address (even if it's split on 2 lines) and PASTE it into your browser. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12913187 or just open pubmed < http://www.ncbi.nlm.nih.gov/entrez/query.fcgi > and SEARCH for 12913187. remember to display the 'abstract.' hope it works... ariela ==== > Sorry! No luck again > Raj > ******** > ----- Original Message ----- > From: Wendy Siegel <[log in to unmask]> > To: <[log in to unmask]> > Sent: Wednesday, October 13, 2004 11:42 PM > Subject: Re: FW:Curcumin/ CDP choline = istradefylline > > > > The link got broken when I forwarded the message. Try this one: > > http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dop > > t=Abstract&list_uids=12913187 > > > > Wendy > > > > -----Original Message----- > > From: Parkinson's Information Exchange Network > > [mailto:[log in to unmask]] On Behalf Of Brightline > > Sent: Tuesday, October 12, 2004 1:48 PM > > To: [log in to unmask] > > Subject: Re: FW:Curcumin/ CDP choline > > > > HI Wendy: > > I cannot open this site! > > Raj > > ********** > > ----- Original Message ----- > > From: Wendy Siegel <[log in to unmask]> > > To: <[log in to unmask]> > > Sent: Monday, October 11, 2004 4:47 PM > > Subject: FW:Curcumin/ CDP choline > > > > > > > Hi! > > > > > > I have forwarded this edited post from another list. Ron Hutton is the > > > writer. > > > > > > > > > > > > Wendy > > > > > > > > > > > > -----Original Message----- > > > > > > > > > > > > Hello All, > > > > > > Apologies for my very occasional posts on non FSR > > items, > > > but there is a new treatment that is making swift progress, and I find > > > their recovery is similar to what I have experienced with the above > > > supplements (Curcumin/ CDP choline). > > > > > > The new treatment is quite different to conventional drugs > > > which normally treat the dopamine generation system. It works on the > > > A2A (adenisone) receptors, adenosine is a neuromodulator. The trial > > is > > > at the advanced stage 3, and is reporting startling improvements > > > > > > See > > > > > > http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve > > > > > <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&do > > > pt=Abstract&list_uids=12913187> > > > &db=pubmed&dopt=Abstract&list_uids=12913187 > > > > > > It has been reported by a user on the trial that " one of the > > first > > > signs that the drug's working is increased dyskinesia. Some of the key > > > measurements for the study are increased "On Time", decease in sinemet > > > usage, and smoother, less dyskinetic motor responses." > > > > > > > > > > > > > > > > > > This is very interesting since it is exactly what i experienced > > during > > > the two years I improved with the above supplements, > > > > > > curcumin /bioperine and CDP choline (citicoline). > > > > > > I experienced increased dyskinesia which enabled me to halve my > > > Sinemet usage in 2 years. > > > > > > Others who started the supplements reported to me they were > > > suffering increased dyskinesia. I would just like to point out this is > > > good news and to then reduce your sinemet. The recovery is following > > the > > > same pattern as the latest drug, but the drug is clearly superior, > > > giving much more rapid recovery. > > > > > > I would appreciate any update from anyone who has had the > > > patience and tenacity to keep the supplements going despite the slow > > > progress. > > > > > > Ron > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <http://us.adserver.yahoo.com/l?M=315388.5455590.6541273.1901630/D=grphe > > > alth/S=:HM/A=2372352/rand=103105651> > > > > > > > > > > > > > > > ---------------------------------------------------------------------- > > > To sign-off Parkinsn send a message to: > > mailto:[log in to unmask] > > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: > > mailto:[log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > > In the body of the message put: signoff parkinsn > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn